home / stock / ctlt / ctlt articles


CTLT Articles, Catalent Inc. - From 02/06/24

Stock Information

Company Name: Catalent Inc.
Stock Symbol: CTLT
Market: NYSE
Website: catalent.com

Menu

CTLT CTLT Quote CTLT Short CTLT News CTLT Articles CTLT Message Board
Get CTLT Alerts

News, Short Squeeze, Breakout and More Instantly...

Catalent Analysts Raise Their Forecasts Following Acquisition News | Benzinga

On Monday, Catalent, Inc. (NYSE: CTLT) announced it will be acquired by Novo Holdings. Novo Holdings will acquire all outstanding shares of Catal...

Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

INVESTIGATION ALERT: Halper Sadeh LLC Investigates EVBG, CTLT, KRTX | Benzinga

NEW YORK, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potentia...

Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected fi...

What's Going On With Eli Lilly Stock Today? | Benzinga

Eli Lilly And Co’s (NYSE:LLY) shares are trading higher with a session volume of 1.683 million versus an average volume of 3.12 million,...

Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday | Benzinga

U.S. stocks traded lower, with the Dow Jones falling over 300 points on Monday. Shares of The Estée Lauder Companies Inc. (NYSE: EL) rose s...

CTLT Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Catalent to Novo Holdings | Benzinga

MONSEY, N.Y., Feb. 05, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the price of $63.50 per...

Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug Demand | Benzinga

Maker of ‘miracle’ weight loss drugs Ozempic and Wegovy, Novo Nordisk A/S (NYSE:NVO) has announced the acquisition of three fill-finish...

What Happened With Caltalent Stock? | Benzinga

Catalent, Inc. (NYSE: CTLT) shares traded higher on Tuesday. Following losses at the end of October, the stock has rebounded over the past month. W...

Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality' | Benzinga

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vishay Intertechnology, Inc. (NYSE: VSH) is "way too cheap." He ...

Previous 10 Next 10